​

Acumen Pharmaceuticals (ABOS) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChartTranscripts

ABOS Stock Forecast

Acumen Pharmaceuticals (ABOS) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $7.00, with a high of $7.00 and a low of $7.00. This represents a 614.29% increase from the last price of $0.98.

- $1 $2 $3 $4 $5 $6 $7 High: $7 Avg: $7 Low: $7 Last Closed Price: $0.98

ABOS Stock Rating

Acumen Pharmaceuticals stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 7 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 7 Strong Sell Sell Hold Buy Strong Buy

ABOS Price Target Upside V Benchmarks

TypeNameUpside
StockAcumen Pharmaceuticals614.29%
SectorHealthcare Stocks 33.91%
IndustryBiotech Stocks 83.49%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$7.00
Last Closing Price$0.98$0.98$0.98
Upside/Downside--614.29%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 2515---6
Mar, 2515---6
Feb, 2515---6
Jan, 2515---6
Dec, 2415---6
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 25, 2024David HoangCitigroup$7.00$3.41105.28%614.29%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 03, 2024H.C. WainwrightBuyBuyhold
Jul 25, 2024CitigroupBuyinitialise
May 18, 2023BTIGBuyinitialise

Financial Forecast

EPS Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.08$-1.71----
Avg Forecast$-1.07$-1.58$-1.86$-1.80$-1.96$-1.82
High Forecast$-0.97$-1.48$-1.61$-1.63$-1.96$-1.82
Low Forecast$-1.15$-1.72$-2.04$-1.97$-1.96$-1.82
Surprise %0.93%8.23%----

Revenue Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast$7.50M----$26.53M
High Forecast$7.50M----$26.53M
Low Forecast$7.50M----$26.53M
Surprise %------

Net Income Forecast

$-105M $-93M $-81M $-69M $-57M $-45M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-52.37M$-102.33M----
Avg Forecast$-52.37M$-81.67M$-88.80M$-87.50M$-95.27M$-88.47M
High Forecast$-47.34M$-71.88M$-78.21M$-79.23M$-95.27M$-88.47M
Low Forecast$-55.95M$-83.69M$-99.40M$-95.77M$-95.27M$-88.47M
Surprise %-25.29%----

ABOS Forecast FAQ

Is Acumen Pharmaceuticals stock a buy?

Acumen Pharmaceuticals stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 7 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Acumen Pharmaceuticals is a favorable investment for most analysts.

What is Acumen Pharmaceuticals's price target?

Acumen Pharmaceuticals's price target, set by 7 Wall Street analysts, averages $7 over the next 12 months. The price target range spans from $7 at the low end to $7 at the high end, suggesting a potential 614.29% change from the previous closing price of $0.98.

How does Acumen Pharmaceuticals stock forecast compare to its benchmarks?

Acumen Pharmaceuticals's stock forecast shows a 614.29% upside, outperforming the average forecast for the healthcare stocks sector (33.91%) and outperforming the biotech stocks industry (83.49%).

What is the breakdown of analyst ratings for Acumen Pharmaceuticals over the past three months?

  • April 2025: 16.67% Strong Buy, 83.33% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 16.67% Strong Buy, 83.33% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 16.67% Strong Buy, 83.33% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Acumen Pharmaceuticals’s EPS forecast?

Acumen Pharmaceuticals's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.86, marking a 8.77% increase from the reported $-1.71 in 2024. Estimates for the following years are $-1.8 in 2026, $-1.96 in 2027, and $-1.82 in 2028.

What is Acumen Pharmaceuticals’s revenue forecast?

Acumen Pharmaceuticals's average annual revenue forecast for its fiscal year ending in December 2025 is $0, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $0, followed by $0 for 2027, and $26.53M for 2028.

What is Acumen Pharmaceuticals’s net income forecast?

Acumen Pharmaceuticals's net income forecast for the fiscal year ending in December 2025 stands at $-88.802M, representing a -13.22% decrease from the reported $-102M in 2024. Projections indicate $-87.496M in 2026, $-95.274M in 2027, and $-88.468M in 2028.